SOPHARMA AD - Consolidated financial report as at 30 September 2023

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Consolidated financial report as at 30 September 2023.rar Consolidated financial report as at 30 September 2023
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 200 / 2023

Date of issue: 2023-11-29

Short name of the issuer

SOPHARMA AD

Subject

Consolidated financial report as at 30 September 2023

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Consolidated financial report according to IFRS as at 30 September 2023
Notes to the consolidated financial report as at 30 September 2023
Consolidated management report as at 30 September 2023
Insider information as at 30 September 2023
Additional information as at 30 September 2023
Consolidated financial report according to BFSC standards as at 30 September 2023
Information according to Annex 4 of Ordinance 2 as at 30 September 2023
Declaration by the responsible directors as at 30 September 2023

Annexes

File Description

Consolidated financial report as at 30 September 2023.rarConsolidated financial report as at 30 September 2023.rar Consolidated financial report as at 30 September 2023

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2023-11-29 Ognian Ivanov Donev Executive Director